Wilmington, Delaware, United States, Transparency Market Research, Inc. , Aug. 14, 2024 (GLOBE NEWSWIRE) -- The breast biopsy devices market (marché des appareils de biopsie mammaire) was projected to attain US$ 2.1 billion in 2023. It is likely to garner a 5.7% CAGR from 2024 to 2034, and by 2034, the market is expected to attain US$ 3.9 billion. Increasing awareness regarding breast cancer, coupled with government initiatives and screening programs, encourages more women to undergo regular screenings, thereby boosting the demand for biopsy devices.
Increasing focus on personalized medicine and patient-centric care necessitates accurate and timely diagnosis, spurring the adoption of advanced biopsy devices that enable precise pathological analysis and treatment planning. Increasing preference for minimally invasive biopsy procedures over traditional surgical biopsies due to lower risk, faster recovery, and reduced scarring drives the adoption of advanced biopsy devices.
Companion diagnostic tests play a crucial role in identifying specific biomarkers and molecular targets associated with breast cancer subtypes. The demand for biopsy devices compatible with the tests is all set to rise, driving the market growth. There is an increasing trend towards genetic screening for breast cancer risk assessment, with advancements in genetic testing technologies. The trend drives the need for biopsy devices to confirm diagnoses and guide treatment decisions based on genetic predispositions.
Request a PDF Sample of this Report Now!
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=86096
Key Findings of the Market Report
- Patient preference for outpatient settings accelerates the demand for biopsy devices, suitable for use in outpatient clinics and diagnostic centers.
- Focus on early detection and intervention will contribute to the demand for biopsy devices as part of routine screening protocols, especially among high risk populations.
- Integration of telemedicine and remote monitoring enables healthcare providers to conduct virtual consultations, review biopsy results remotely, and facilitate multidisciplinary care coordination.
Market Trends for Breast Biopsy
- Expanding applications beyond cancer diagnosis creates new market opportunities for biopsy device manufacturers.
- Quality assurance initiatives and standardization efforts in biopsy procedures aim to ensure consistency, accuracy, and reproducibility in pathological assessments.
- Emphasis on precision medicine and targeted therapies underscore the importance of accurate molecular profiling and subtype classification.
- Biopsy devices that enable comprehensive molecular characterization of breast tumors facilitate personalized treatment strategies, driving demand in the market.
- Transition towards value-based healthcare models incentivizes healthcare providers to prioritize cost-effective diagnostic strategies that offer optimal clinical outcomes.
- Biopsy devices that demonstrate superior clinical efficacy, cost-effectiveness, and patient satisfaction are likely to drive market growth.
Global Market for Breast Biopsy: Regional Outlook
- North America has a relatively high incidence of breast cancer, driving the demand for breast biopsy devices for early detection, diagnosis, and treatment planning.
- There is a strong emphasis on early detection of breast cancer in the region, supported by widespread screening programs and public health initiatives.
- North America is a hub for medical technology innovation, with continuous advancements in breast biopsy device technologies such as vacuum-assisted biopsy systems, ultrasound-guided biopsy devices, and MRI-guided biopsy systems.
- On the other hand, trends in Asia Pacific is also creating opportunities for the market. Increasing healthcare expenditure in countries like China, Japan, South Korea, and India allows for greater investment in medical devices and technologies, which leads to increased adoption of breast biopsy devices, particularly in urban centers with higher healthcare spending.
- Governments in the region region are increasingly investing in cancer control programs, including initiatives for early detection, diagnosis, and treatment of breast cancer. Government funding and support for healthcare infrastructure development drive the growth of the breast biopsy devices market.
Unlock Growth Potential in Your Industry! Download PDF Brochure: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=86096
Breast Biopsy Devices Market: Key Players
Companies are focusing on expanding their geographical presence through strategic partnerships, acquisitions, and distribution agreements, which enables them to tap into new markets and reach a wider customer base.
Investment in research and development is crucial for staying ahead in the competitive market. Companies are continually investing in research to develop innovative biopsy technologies, improve device performance, and enhance patient outcomes. The following companies are well-known participants in the breast biopsy devices market:
- Hologic Inc.
- Becton, Dickinson and Company (BD)
- Medtronic
- Danaher Corporation
- Siemens Healthineers AG
- Mammotome (Devicor Medical Products, Inc.)
- Carestream Health
- AURORA HEALTHCARE US CORP.
- Stryker
Key Developments
- In 2023, Mammotome introduced the HydroMARK Plus Breast Biopsy Site Marker, aiming to improve ultrasound visibility, simplify locating, and reduce displacement during surgical procedures.
- In 2022, TransMed7, LLC revealed the successful execution of the initial clinical cases utilizing the ultimate commercial version of the Sparrow device. The device, a part of the innovative SpeedBird family, features vacuum-assisted technology and enables Single Insertion / Multiple Collection (SIMC) Breast Biopsy procedures. The milestone procedures were conducted by Dr. Edgar Staren, a prominent surgeon and former President of the American Society of Breast Surgeons (ASBrS).
Breast Biopsy Devices Market Segmentation
By Product Type
- Core Needle Biopsy Devices
- Vacuum-assisted Biopsy Devices
- Fine Needle Aspiration Biopsy Devices
- Surgical Biopsy Devices
- Others (Image-guided Biopsy Devices, etc.)
By Guidance Technique
- Ultrasound-guided Biopsy
- MRI-guided Biopsy
- Mammography-guided Biopsy
- Stereotactic-guided Biopsy
By Application
- Screening
- Diagnostic
- Surveillance
By End User
- Hospitals
- Specialty Clinics
- Diagnostic Imaging Centers
- Ambulatory Surgical Centers
By Region
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East & Africa
Buy this Premium Research Report: https://www.transparencymarketresearch.com/checkout.php?rep_id=86096<ype=S
More Trending Reports by Transparency Market Research –
- Liquid Biopsy Market - The global liquid biopsy market (marché de la biopsie liquide) is projected to advance at a CAGR of 8.8% from 2023 to 2031.
- Cancer Biopsy Market - The global cancer biopsy market (marché des biopsies du cancer) is projected to expand at a CAGR of 11.4% during the forecast period from 2023 to 2031.
- Mesotherapy Market – The global mesotherapy market (marché de la mésothérapie) is expected to grow at a CAGR of 5.2% from 2024 to 2034 and reach US$ 1.4 Billion by the end of 2034.
- Ophthalmic Sutures Market – The global ophthalmic sutures market (marché des sutures ophtalmiques) is expected to grow at a CAGR of 6.5% from 2024 to 2034 and reach US$ 1.3 Billion by the end of 2034.
About Transparency Market Research
Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Contact:
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Email: sales@transparencymarketresearch.com
Follow Us: LinkedIn| Twitter| Blog | YouTube
